Results 151 to 160 of about 13,492,077 (298)

HIV/AIDS surveillance in Europe 2013: surveillance report

open access: yes, 2014
xix + 95 p.The HIV epidemic has continued to spread in Europe since 2004 despite advances in medical treatment and new prevention options. In 2013, more than 136 000 new HIV cases were diagnosed across Europe and central Asia, according to the most ...
European Centre for Disease Prevention and Control   +1 more
core  

SPG4 and Dementia: Expanding the Clinical Spectrum

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing.
Emanuele Panza   +19 more
wiley   +1 more source

Statement of Intent on Open Research Europe [PDF]

open access: yes
La présente déclaration d’intention est signée par des organismes publics de financement de la recherche, des organisations de chercheurs et les ministères nationaux (ci-après dénommés « Signataires ») qui font partie du Groupe d’intérêt Open Research ...
Open Research Europe
core  

The Social Dimension of Europe

open access: yes, 2015
Anna Triandafyllidou, Ruby Gropas
openaire   +1 more source

Social Democracy in Europe 4.0

open access: yes, 2017
In 1983, after a coalition of centre-rights (Kohl) and liberals (Genscher) pushed the social democrats (Brandt, Schmidt) out of government, German-British sociologist Lord Ralf Dahrendorf concluded: "We are witnessing the end of the social-democratic century in the OECD world." 1 He argued-as many others believed at that time-that the social democratic
Gazier, Bernard, Schmid, Günther
openaire   +3 more sources

Advancing Age Modulates Associations Between Cognitive Impairment and Brain Volumes in Early MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Cognitive impairment is common in multiple sclerosis (MS), but manifestations following the first demyelinating event are relatively unexplored. We investigated cross‐sectional associations between magnetic resonance imaging (MRI)–derived brain volumes and the presence of cognitive impairment outcomes five years after the first ...
Piriyankan Ananthavarathan   +14 more
wiley   +1 more source

Added Prognostic Value of EEG Reactivity in Comatose Patients Following Cardiac Arrest

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the added prognostic value of EEG reactivity for favorable outcome compared with background analysis during and after targeted temperature management (TTM). Methods Prospective observational cohort study of comatose post–cardiac arrest patients admitted to a single academic center between 2017 and 2022, all undergoing ...
Sarah Caroyer   +11 more
wiley   +1 more source

New Social Policy Ideas in the Making: The Case of Central and Eastern Europe [PDF]

open access: yes
Central and Eastern European countries have experienced a rapid transformation of their economic, political and welfare regime(s). From a state-paternalist welfare state, post-communist countries are now moving towards something new.
Cerami, Alfio
core  

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni   +19 more
wiley   +1 more source

National drug policies

open access: yes, 1979
iii, 99 p.Until the 1950s, governments were mainly concerned with the quality control of drugs and their compliance with specifications and with methods for the analysis of the active components.
World Health Organization. Regional Office for Europe
core  

Home - About - Disclaimer - Privacy